AZASETRON HYDROCHLORIDE

AZASETRON HYDROCHLORIDE

Biochem/physiol Actions

Azasetron (Y-25130) is an orally active, potent and selective 5-HT3 receptor antagonist (binding Ki = 0.33 nM against [3H]granisetron/rat small intestine, 2.9 nM against [3H]quipazine/rat cortex; little or no affinity toward H1,d5-HT1A/2, Dopamine D1/2, α1/α2 adrenoceptor, muscarinic receptors) with in vivo antiemetic efficacy (0.1-0.3 mg/kg i.v. & 0.1-1 mg/kg p.o.; dogs, ferrets). Y-25130 inhibits 5-HT-induced bradycardia in anesthetized rats (ED50 = 820 ng/kg i.v.), while concurrent intrahippocampal infusion (1.0 µg/side) prevents memory function impairment caused by muscarinic acetylcholine receptor antagonist scopolamine (3.2 µg/side), but not NMDA receptor antagonist CPP (32 ng/side).

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3576390 AZASETRON HYDROCHLORIDE white to beige DBMKBKPJYAHLQP-UHFFFAOYSA-N 1S/C17H20ClN3O3.ClH/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21;/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23);1H SIGMA-ALDRICH H2O: 2 mg/mL, clear powder ≥98% (HPLC)
£501.43 (exc VAT) per 25MG
-
+
3576391 AZASETRON HYDROCHLORIDE white to beige DBMKBKPJYAHLQP-UHFFFAOYSA-N 1S/C17H20ClN3O3.ClH/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21;/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23);1H SIGMA-ALDRICH H2O: 2 mg/mL, clear powder ≥98% (HPLC)
£124.24 (exc VAT) per 5MG
-
+